National Institutes of Health (NIH)

NIH-sponsored Phase 1 trial tested mRNA vaccine

Gene expression data suggest potential role of sex chromosomes.

RADx efforts seek to create capacity for 6 million daily tests by the end of 2020, address underserved populations.

Multicenter HOPE Act study expands pool of available kidneys

IL-17, known for driving inflammation, also puts on the brakes, NIH scientists report

NIAID celebrates pivotal step toward expanding HIV prevention choices for women.

Foot ulcers are the leading cause of lower limb amputations in the United States.

Multi-site trial to test candidate developed by Moderna and NIH.

The new five-year program will leverage existing data and technologies to develop solutions for the continent’s most pressing clinical and public health problems.